INS and obesity disorder: By reducing the steroid hormone ecdysone, we created a new obese-fly model (OBL) that we propose can be used to investigate obesity-related pathways, including insulin resistance, altered fat metabolism, chronic inflammation, immune system dysfunction and cardiac defects.